For: | Shrivastava S, Mukherjee A, Ray RB. Hepatitis C virus infection, microRNA and liver disease progression. World J Hepatol 2013; 5(9): 479-486 [PMID: 24073299 DOI: 10.4254/wjh.v5.i9.479] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v5/i9/479.htm |
Number | Citing Articles |
1 |
Jyoti Kureel, Aijaz A John, Manisha Dixit, Divya Singh. MicroRNA-467g inhibits new bone regeneration by targeting Ihh/Runx-2 signaling. The International Journal of Biochemistry & Cell Biology 2017; 85: 35 doi: 10.1016/j.biocel.2017.01.018
|
2 |
Jie Huang, Xinlei Fu, Xue Chen, Shuang Xu, Jian Yu. Silencing of miR-486 alleviates LPS-stimulated inflammatory response of macrophages through targeting SIRT1. RSC Advances 2019; 9(30): 17057 doi: 10.1039/C9RA01374A
|
3 |
Iqra Almas, Samia Afzal, Muhammad Usman Ashraf, Khadija Zahid, Asif Rasheed, Muhammad Idrees. Studies on circulating microRNAs: Members of Let-7 family and their correlation with Hepatitis C virus disease pathogenesis and treatment concerns. 2017 14th International Bhurban Conference on Applied Sciences and Technology (IBCAST) 2017; : 174 doi: 10.1109/IBCAST.2017.7868051
|
4 |
Maryam Shafaati, Marzieh Jamalidoust, Mohammad Kargar, Ehsan Arefian, Farshid Kafilzadeh. Downregulation of hepatitis C virus replication by miR‐196a using lentiviral vectors. Microbiology and Immunology 2021; 65(4): 161 doi: 10.1111/1348-0421.12875
|
5 |
Pradip B. Devhare, Robert Steele, Adrian M. Di Bisceglie, David E. Kaplan, Ratna B. Ray. Differential Expression of MicroRNAs in Hepatitis C Virus-Mediated Liver Disease Between African Americans and Caucasians: Implications for Racial Health Disparities. Gene Expression 2017; 17(2): 89 doi: 10.3727/105221616X693594
|
6 |
Mehmet Celikbilek, Mevlut Baskol, Serpil Taheri, Kemal Deniz, Serkan Dogan, Gokmen Zararsiz, Sebnem Gursoy, Kadri Guven, Omer Ozbakır, Munis Dundar, Mehmet Yucesoy. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World Journal of Hepatology 2014; 6(8): 613-620 doi: 10.4254/wjh.v6.i8.613
|
7 |
Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacology & Therapeutics 2015; 145: 103 doi: 10.1016/j.pharmthera.2014.09.005
|
8 |
Wafaa El-Zefzafy, Hanan Eltokhy, Nagwa Abd El-Ghaffar Mohamed, Zakia Abu-Zahab. Significance of Serum Cytokeratin-18 in Prediction of Hepatocellular Carcinoma in Chronic Hepatitis C Infected Egyptian Patients. Open Access Macedonian Journal of Medical Sciences 2015; 3(1): 117 doi: 10.3889/oamjms.2015.021
|
9 |
J. P. Ren, R. S. Ying, Y. Q. Cheng, L. Wang, M. El Gazzar, G. Y. Li, S. B. Ning, J. P. Moorman, Z. Q. Yao. HCV‐induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T‐cell development. Journal of Viral Hepatitis 2016; 23(10): 755 doi: 10.1111/jvh.12537
|
10 |
Concetta Panebianco, Chiara Saracino, Valerio Pazienza. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression. Tumor Biology 2014; 35(8): 7307 doi: 10.1007/s13277-014-2075-x
|
11 |
Tarek M. K. Motawi, Sherine M. Rizk, Olfat G. Shaker, Olfat Z. H. Mokhtar, David R. Booth. MicroRNAs as Predictor Markers for Response to Interferon Treatment of Chronic Hepatitis C Genotype-4 in Egyptian Patients. PLOS ONE 2015; 10(3): e0121524 doi: 10.1371/journal.pone.0121524
|
12 |
Mohammad Moradi, Farzad Mozafari, Shirin Hosseini, Rouhullah Rafiee, Faezeh Ghasemi. A concise review on impacts of microRNAs in biology and medicine of hepatitis C virus. Gene Reports 2020; 20: 100761 doi: 10.1016/j.genrep.2020.100761
|
13 |
Simonetta Bandiera, Sophie Pernot, Hussein El Saghire, Sarah C. Durand, Christine Thumann, Emilie Crouchet, Tao Ye, Isabel Fofana, Marine A. Oudot, Jochen Barths, Catherine Schuster, Patrick Pessaux, Markus H. Heim, Thomas F. Baumert, Mirjam B. Zeisel, M. S. Diamond. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis. Journal of Virology 2016; 90(14): 6387 doi: 10.1128/JVI.00619-16
|
14 |
Rui Hua, Xiaoyu Jiang, Lingxia Qi, Shanshan Guan, Ziyu Kuai, Yongbo Qiao, Yan Xu, Xin Gong, Yuhua Shi, Wei Kong, Junqi Niu, Hao Zhang, Yaming Shan. Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region. Immunologic Research 2018; 66(1): 67 doi: 10.1007/s12026-017-8962-7
|
15 |
Urbi Mukhopadhyay, Shampa Chanda, Upayan Patra, Arpita Mukherjee, Santanu Rana, Anupam Mukherjee, Mamta Chawla-Sarkar. Synchronized Orchestration of miR-99b and let-7g Positively Regulates Rotavirus Infection by Modulating Autophagy. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-38473-8
|
16 |
Shubham Shrivastava, Robert Steele, Ranjit Ray, Ratna B. Ray. MicroRNAs: Role in hepatitis C virus pathogenesis. Genes & Diseases 2015; 2(1): 35 doi: 10.1016/j.gendis.2015.01.001
|
17 |
Nadia Mohamed El-Guendy, Reham Helwa, Medhat Salah El-Halawany, Shimaa Abdel Rahman Ali, Marwa Tantawy Aly, Nelly Hasan Alieldin, Shawky Abdel Hamid Fouad, Hany Saeid, Abdel-Hady Ali Abdel-Wahab. The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study. Hepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.33881
|
18 |
Qian Yang, Suzhen Fu, Jie Wang. Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758. Archives of Virology 2014; 159(11): 2997 doi: 10.1007/s00705-014-2167-3
|
19 |
Jennifer Louten, Michael Beach, Kristina Palermino, Maria Weeks, Gabrielle Holenstein. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomarker Insights 2015; : BMI.S29512 doi: 10.4137/BMI.S29512
|
20 |
E. G. Meissner, A. Kohli, K. Virtaneva, D. Sturdevant, C. Martens, S. F. Porcella, J. G. McHutchison, H. Masur, S. Kottilil. Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis. Journal of Viral Hepatitis 2016; 23(7): 496 doi: 10.1111/jvh.12510
|
21 |
Terence N. Bukong, Banishree Saha, Gyongyi Szabo. Hepatitis C Virus II. 2016; : 137 doi: 10.1007/978-4-431-56101-9_5
|
22 |
Mahmoud Kandeel. Oncogenic Viruses-Encoded microRNAs and Their Role in the Progression of Cancer: Emerging Targets for Antiviral and Anticancer Therapies. Pharmaceuticals 2023; 16(4): 485 doi: 10.3390/ph16040485
|
23 |
Yue Feng, Yue-Mei Feng, Yang Feng, Caixia Lu, Li Liu, Xiaomei Sun, Jiejie Dai, Xueshan Xia. Identification and Characterization of Liver MicroRNAs of the Chinese Tree Shrew via Deep Sequencing. Hepatitis Monthly 2015; 15(10) doi: 10.5812/hepatmon.29053
|
24 |
Alyaa S. Abdel Halim, Hassan Ahmed Rudayni, Anis Ahmad Chaudhary, Mohamed A. M. Ali. MicroRNAs: Small molecules with big impacts in liver injury. Journal of Cellular Physiology 2023; 238(1): 32 doi: 10.1002/jcp.30908
|
25 |
Irina Cardoso-Lezama, Erika Ramos-Tovar, Jaime Arellanes-Robledo, Eduardo E. Vargas-Pozada, Verónica Rocío Vásquez-Garzón, Saúl Villa-Treviño, Pablo Muriel. Serum α-SMA is a potential noninvasive biomarker of liver fibrosis. Toxicology Mechanisms and Methods 2024; 34(1): 13 doi: 10.1080/15376516.2023.2244061
|
26 |
Paul Ravi Waldron, Mark Holodniy. MicroRNA and hepatitis C virus- challenges in investigation and translation: a review of the literature. Diagnostic Microbiology and Infectious Disease 2014; 80(1): 1 doi: 10.1016/j.diagmicrobio.2014.05.024
|
27 |
Dinakaran Thirumalai, Woo Ryung Kim, Hyeyoung Joo, Thenmozhi Rajarathinam, Eun Gyung Park, Yun Ju Lee, Hyun-jong Paik, Jaewon Lee, Heui-Soo Kim, Seung-Cheol Chang. Disposable microRNA biosensors based on dual-role polymer-dispersed silver nanowires for diagnosis of viral hemorrhagic septicemia virus infection in olive flounder. Aquaculture 2024; 580: 740287 doi: 10.1016/j.aquaculture.2023.740287
|
28 |
Nicky Joshi, Madhuri Chandane Tak, Anupam Mukherjee. The involvement of microRNAs in HCV and HIV infection. Therapeutic Advances in Vaccines and Immunotherapy 2022; 10 doi: 10.1177/25151355221106104
|
29 |
Julian Gomez-Cambronero, Kristen Fite, Taylor E. Miller. How miRs and mRNA deadenylases could post-transcriptionally regulate expression of tumor-promoting protein PLD. Advances in Biological Regulation 2018; 68: 107 doi: 10.1016/j.jbior.2017.08.002
|
30 |
Liang‐Hao Hu, Jun‐Tao Ji, Zhao‐Shen Li. Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis. Journal of Cellular and Molecular Medicine 2015; 19(9): 2049 doi: 10.1111/jcmm.12603
|
31 |
Javid Sadri Nahand, Farah Bokharaei‐Salim, Arash Salmaninejad, Abolfazl Nesaei, Fatemeh Mohajeri, Azadeh Moshtzan, Alireza Tabibzadeh, Mohammad Karimzadeh, Mohsen Moghoofei, Arezo Marjani, Shoeleh Yaghoubi, Hossein Keyvani. microRNAs: Key players in virus‐associated hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(8): 12188 doi: 10.1002/jcp.27956
|
32 |
Yong Q. Cheng, Jun P. Ren, Juan Zhao, Jia M. Wang, Yun Zhou, Guang Y. Li, Jonathan P. Moorman, Zhi Q. Yao. MicroRNA‐155 regulates interferon‐γ production in natural killer cells via Tim‐3 signalling in chronic hepatitis C virus infection. Immunology 2015; 145(4): 485 doi: 10.1111/imm.12463
|
33 |
Saroj Sharma, Vaishali Kaushik, Mukta Kulshrestha, Vishvanath Tiwari. MicroRNA in Human Infectious Diseases. 2024; : 77 doi: 10.1016/B978-0-323-99661-7.00007-2
|
34 |
Shivaprasad Shwetha, Geetika Sharma, Harsha Raheja, Amit Goel, Rakesh Aggarwal, Saumitra Das. Interaction of miR-125b-5p with Human antigen R mRNA: Mechanism of controlling HCV replication. Virus Research 2018; 258: 1 doi: 10.1016/j.virusres.2018.09.006
|
35 |
Jihae Baek, Soowon Kang, Hyeyoung Min. MicroRNA-targeting therapeutics for hepatitis C. Archives of Pharmacal Research 2014; 37(3): 299 doi: 10.1007/s12272-013-0318-9
|
36 |
Murali Ganesan, Sathish Kumar Natarajan, Jinjin Zhang, Justin L. Mott, Larisa I. Poluektova, Benita L. McVicker, Kusum K. Kharbanda, Dean J. Tuma, Natalia A. Osna. Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(11): G930 doi: 10.1152/ajpgi.00021.2016
|
37 |
Anupam Mukherjee, Shubham Shrivastava, Joydip Bhanja Chowdhury, Ranjit Ray, Ratna B. Ray, B. Williams. Transcriptional Suppression of miR-181c by Hepatitis C Virus Enhances Homeobox A1 Expression. Journal of Virology 2014; 88(14): 7929 doi: 10.1128/JVI.00787-14
|
38 |
Hongwei Wang, Haili Gao, Shupeng Duan, Xinwen Song. Inhibition of microRNA-199a-5p reduces the replication of HCV via regulating the pro-survival pathway. Virus Research 2015; 208: 7 doi: 10.1016/j.virusres.2015.05.002
|
39 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
40 |
Karin Lemuth, Steffen Rupp. RNA and DNA Diagnostics. RNA Technologies 2015; : 259 doi: 10.1007/978-3-319-17305-4_13
|
41 |
Jinying Zhao, Yanhua Wang, Huahua Su, Lijia Su. Non-coding RNAs as biomarkers for hepatocellular carcinoma—A systematic review. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101736 doi: 10.1016/j.clinre.2021.101736
|
42 |
Navneet Kaur, Gitanjali Goyal, Ravinder Garg, Chaitanya Tapasvi, Sonia Chawla, Rajneet Kaur. Potential role of noninvasive biomarkers during liver fibrosis. World Journal of Hepatology 2021; 13(12): 1919-1935 doi: 10.4254/wjh.v13.i12.1919
|
43 |
Simonetta Bandiera, Sébastien Pfeffer, Thomas F. Baumert, Mirjam B. Zeisel. miR-122 – A key factor and therapeutic target in liver disease. Journal of Hepatology 2015; 62(2): 448 doi: 10.1016/j.jhep.2014.10.004
|
44 |
Yemiao Chen, Catherine M. Verfaillie. MicroRNAs: the fine modulators of liver development and function. Liver International 2014; 34(7): 976 doi: 10.1111/liv.12496
|
45 |
Anupam Mukherjee, Adrian M. Di Bisceglie, Ratna B. Ray, M. S. Diamond. Hepatitis C Virus-Mediated Enhancement of MicroRNA miR-373 Impairs the JAK/STAT Signaling Pathway. Journal of Virology 2015; 89(6): 3356 doi: 10.1128/JVI.03085-14
|
46 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
47 |
Shahzeb Hassan, Ellen Sidransky, Nahid Tayebi. The role of epigenetics in lysosomal storage disorders: Uncharted territory. Molecular Genetics and Metabolism 2017; 122(3): 10 doi: 10.1016/j.ymgme.2017.07.012
|
48 |
Kendall R. Van Keuren‐Jensen, Ivana Malenica, Amanda L. Courtright, Layla T. Ghaffari, Alex P. Starr, Raghu P. Metpally, Taylor A. Beecroft, Elizabeth W.J. Carlson, Jeffrey A. Kiefer, Paul J. Pockros, Jorge Rakela. microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C. Liver International 2016; 36(3): 334 doi: 10.1111/liv.12919
|
49 |
A. B. González-Guerrero, J. Maldonado, S. Herranz, L. M. Lechuga. Trends in photonic lab-on-chip interferometric biosensors for point-of-care diagnostics. Analytical Methods 2016; 8(48): 8380 doi: 10.1039/C6AY02972H
|